Inhalable Drugs Market

May 2021| MRS224A| Market Research Studies

Report Highlights

The scope of this report covers the different types of products used as inhalable drugs, impact of COVID-19 on the market, and various applications associated with the use of the therapy. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each product, application, distribution channel, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional inhalable drug markets; it explains the major market drivers of the global inhalable drugs industry, current trends within the industry, major applications, and the regional dynamics of the global inhalable drugs market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global inhalable drugs market.

Report Includes

  • 35 tables and 43 figures
  • An up-to-date analysis of the Global Inhalable Drugs Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Inhalable Drugs Market, and corresponding market share analysis by product, application, distribution channel, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for inhalable drugs, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new drugs, and products still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the inhalable drugs market as compared to overall global economy.
  • Insight into the growth development strategies of major Inhalable Drugs manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including AstraZeneca plc, Mundipharma International Limited, GlaxoSmithKline plc, Mylan N.V., Vectura Group plc, Sanofi S.A., Avalyn Pharma Inc., and others.

Summary

Inhalable drugs are the substances that are inhaled into the lungs for treating various diseases such as, COPD, asthma, bronchospasm, Parkinson's disease, diabetes, and many other diseases. The inhaled drugs are used in various combinations to cure lung diseases. These drugs are available in form of aerosol, dry powder formulation, and spray. Dry powder formulations are inhaled directly into the lungs by taking a deep breath.

The most commonly aerosol used drugs are anti-inflammatory agents and bronchodilators which are used for treating the respiratory diseases. Some of the key factors driving the growth of global inhalable drugs market are rising incidence of respiratory diseases and non-respiratory, increasing geriatric population, and advancement in the inhalable drugs.

Furthermore, the strong presence of various leading players is creating lucrative opportunities for the growth of global inhalable drugs market. The COVID-19 pandemic had a positive impact on the Inhalable Drugs market with the increased number of patients suffering from respiratory diseases. This has further increased the patient pool in the hospital thereby, increasing the demand of inhalable drugs.

The Global Inhalable Drugs Market was valued at $26.18 billion in 2020 and is expected to witness a steady growth at a CAGR of 7.06%.

  • Table 1 : Global Inhalable Drugs Market, Through 2026
  • Table 2 : Global Inhalable Drugs, by Product, Through 2026
  • Table 3 : Global Inhalable Drugs, by Application, Through 2026
  • Table 4 : Global Inhalable Drugs, by Distribution Channel, Through 2026
  • Table 5 : Global Inhalable Drugs, by Region, Through 2026
  • Table 6 : North America Inhalable Drugs, by Product, Through 2026
  • Table 7 : North America Inhalable Drugs, by Application, Through 2026
  • Table 8 : North America Inhalable Drugs, by Distribution Channel, Through 2026
  • Table 9 : North America Inhalable Drugs, by Country, Through 2026
  • Table 10 : Europe Inhalable Drugs, by Product, Through 2026
  • Table 11 : Europe Inhalable Drugs, by Application, Through 2026
  • Table 12 : Europe Inhalable Drugs, by Distribution Channel, Through 2026
  • Table 13 : Europe Inhalable Drugs, by Country, Through 2026
  • Table 14 : Asia-Pacific Inhalable Drugs, by Product, Through 2026
  • Table 15 : Asia-Pacific Inhalable Drugs, by Application, Through 2026
  • Table 16 : Asia-Pacific Inhalable Drugs, by Distribution Channel, Through 2026
  • Table 17 : Asia-Pacific Inhalable Drugs, by Country, Through 2026
  • Table 18 : South America Inhalable Drugs, by Product, Through 2026
  • Table 19 : South America Inhalable Drugs, by Application, Through 2026
  • Table 20 : South America Inhalable Drugs, by Distribution Channel, Through 2026
  • Table 21 : South America Inhalable Drugs, by Country, Through 2026
  • Table 22 : Middle East & Africa Inhalable Drugs, by Product, Through 2026
  • Table 23 : Middle East & Africa Inhalable Drugs, by Application, Through 2026
  • Table 24 : Middle East & Africa Inhalable Drugs, by Distribution Channel, Through 2026
  • Table 25 : Middle East & Africa Inhalable Drugs, by Country, Through 2026
  • Table 26 : AstraZeneca plc: Financial Performance, Through 2020
  • Table 27 : Mundipharma International Limited: Financial Performance, Through 2020
  • Table 28 : GlaxoSmithKline plc: Financial Performance, Through 2020
  • Table 29 : Mylan N.V.: Financial Performance, Through 2020
  • Table 30 : Vectura Group plc: Financial Performance, Through 2020
  • Table 31 : Sanofi S.A.: Financial Performance, Through 2020
  • Table 32 : Avalyn Pharma Inc.: Financial Performance, Through 2020
  • Table 33 : Quotient Sciences Limited: Financial Performance, Through 2020
  • Table 34 : EffRx Pharmaceuticals SA: Financial Performance, Through 2020
  • Table 35 : Catalent, Inc.: Financial Performance, Through 2020
  • Figure 1 : Global Inhalable Drugs Market
  • Figure 2 : Global Inhalable Drugs, by Value, 2019-2026
  • Figure 3 : Global Inhalable Drugs, by Value, by Product, 2019-2026
  • Figure 4 : Global Inhalable Drugs, by Value, by Application, 2019-2026
  • Figure 5 : Global Inhalable Drugs, by Value, by Distribution Channel, 2019-2026
  • Figure 6 : Global Inhalable Drugs, by Value, by Region, 2020
  • Figure 7 : Global Inhalable Drugs, by Value, by Company, 2020
  • Figure 8 : Global Inhalable Drugs, Product Map, 2020
  • Figure 9 : North America Inhalable Drugs, by Value, 2019-2026
  • Figure 10 : North America Inhalable Drugs, by Value, by Product, 2019-2026
  • Figure 11 : North America Inhalable Drugs, by Value, by Application, 2019-2026
  • Figure 12 : North America Inhalable Drugs, by Value, by Distribution Channel, 2019-2026
  • Figure 13 : North America Inhalable Drugs, by Value, by Country, 2020
  • Figure 14 : Europe Inhalable Drugs, by Value, 2019-2026
  • Figure 15 : Europe Inhalable Drugs, by Value, by Product, 2019-2026
  • Figure 16 : Europe Inhalable Drugs, by Value, by Application, 2019-2026
  • Figure 17 : Europe Inhalable Drugs, by Value, by Distribution Channel, 2019-2026
  • Figure 18 : Europe Inhalable Drugs, by Value, by Country, 2020
  • Figure 19 : Asia-Pacific Inhalable Drugs, by Value, 2019-2026
  • Figure 20 : Asia-Pacific Inhalable Drugs, by Value, by Product, 2019-2026
  • Figure 21 : Asia-Pacific Inhalable Drugs, by Value, by Application, 2019-2026
  • Figure 22 : Asia-Pacific Inhalable Drugs, by Value, by Distribution Channel, 2019-2026
  • Figure 23 : Asia-Pacific Inhalable Drugs, by Value, by Country, 2020
  • Figure 24 : South America Inhalable Drugs, by Value, 2019-2026
  • Figure 25 : South America Inhalable Drugs, by Value, by Product, 2019-2026
  • Figure 26 : South America Inhalable Drugs, by Value, by Application, 2019-2026
  • Figure 27 : South America Inhalable Drugs, by Value, by Distribution Channel, 2019-2026
  • Figure 28 : South America Inhalable Drugs, by Value, by Country, 2020
  • Figure 29 : Middle East & Africa Inhalable Drugs, by Value, 2019-2026
  • Figure 30 : Middle East & Africa Inhalable Drugs, by Value, by Product, 2019-2026
  • Figure 31 : Middle East & Africa Inhalable Drugs, by Value, by Application, 2019-2026
  • Figure 32 : Middle East & Africa Inhalable Drugs, by Value, by Distribution Channel, 2019-2026
  • Figure 33 : Middle East & Africa Inhalable Drugs, by Value, by Country, 2020
  • Figure 34 : AstraZeneca plc: Revenue Share, 2020
  • Figure 35 : Mundipharma International Limited: Revenue Share, 2020
  • Figure 36 : GlaxoSmithKline plc: Revenue Share, 2020
  • Figure 37 : Mylan N.V.: Revenue Share, 2020
  • Figure 38 : Vectura Group plc: Revenue Share, 2020
  • Figure 39 : Sanofi S.A.: Revenue Share, 2020
  • Figure 40 : Avalyn Pharma Inc.: Revenue Share, 2020
  • Figure 41 : Quotient Sciences Limited: Revenue Share, 2020
  • Figure 42 : EffRx Pharmaceuticals SA: Revenue Share, 2020
  • Figure 43 : Catalent, Inc.: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report